The European Randomized Study of Screening for Prostate Cancer – Prostate Cancer Mortality at 13 Years of Follow-up

BACKGROUND: The European Randomized study of Screening for Prostate Cancer (ERSPC) is a randomized multi-center trial with a predefined centralized database, analysis plan and core age group (55–69 years) evaluating prostate-specific antigen (PSA) testing in eight European countries. METHODS: The pr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet
Main Authors: Schröder, Fritz H., Hugosson, Jonas, Roobol, Monique J., Tammela, Teuvo L.J., Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Määttänen, Lissa, Lilja, Hans, Denis, Louis J., Recker, Franz, Paez, Alvaro, Bangma, Chris H., Carlsson, Sigrid, Puliti, Donella, Villers, Arnauld, Rebillard, Xavier, Hakama, Matti, Stenman, Ulf-Hakan, Kujala, Paula, Taari, Kimmo, Aus, Gunnar, Huber, Andreas, van der Kwast, Theo, van Schaik R, Ron H.N., de Koning, Harry J., Moss, Sue M., Auvinen, Anssi
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4427906/
https://ncbi.nlm.nih.gov/pubmed/25108889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)60525-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares